Biomarkers in psychiatric disorders

Adv Clin Chem. 2023:116:183-208. doi: 10.1016/bs.acc.2023.05.005. Epub 2023 Sep 26.

Abstract

Psychiatric disorders represent a significant socioeconomic and healthcare burden worldwide. Of these, schizophrenia, bipolar disorder, major depressive disorder and anxiety are among the most prevalent. Unfortunately, diagnosis remains problematic and largely complicated by the lack of disease specific biomarkers. Accordingly, much research has focused on elucidating these conditions to more fully understand underlying pathophysiology and potentially identify biomarkers, especially those of early stage disease. In this chapter, we review current status of this endeavor as well as the potential development of novel biomarkers for clinical applications and future research study.

Keywords: Biochemical routes; Biomarker discovery; Biomarkers validation; Omics approaches; Sample preparation.

Publication types

  • Review

MeSH terms

  • Biomarkers
  • Bipolar Disorder* / diagnosis
  • Depressive Disorder, Major* / diagnosis
  • Humans
  • Mental Disorders* / diagnosis
  • Schizophrenia* / diagnosis

Substances

  • Biomarkers